Cargando…

Discovery and validation of an INflammatory PROtein-driven GAstric cancer Signature (INPROGAS) using antibody microarray-based oncoproteomics

This study aimed to improve gastric cancer (GC) diagnosis by identifying and validating an INflammatory PROtein-driven GAstric cancer Signature (hereafter INPROGAS) using low-cost affinity proteomics. The detection of 120 cytokines, 43 angiogenic factors, 41 growth factors, 40 inflammatory factors a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puig-Costa, Manuel, Codina-Cazador, Antonio, Cortés-Pastoret, Elisabet, Oliveras-Ferraros, Cristina, Cufí, Sílvia, Flaquer, Sílvia, Llopis-Puigmarti, Francesca, Pujol-Amado, Eulalia, Corominas-Faja, Bruna, Cuyàs, Elisabet, Ortiz, Rosa, Lopez-Bonet, Eugeni, Queralt, Bernardo, Guardeño, Raquel, Martin-Castillo, Begoña, Roig, Josep, Joven, Jorge, Menendez, Javier A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039123/ https://www.ncbi.nlm.nih.gov/pubmed/24722433

Ejemplares similares

The anti-malarial chloroquine overcomes Primary resistance and restores sensitivity to Trastuzumab in HER2-positive breast cancer
por: Cufí, Sílvia, et al.
Publicado: (2013)

Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency
por: Vazquez-Martin, Alejandro, et al.
Publicado: (2012)

Mitophagy-driven mitochondrial rejuvenation regulates stem cell fate
por: Vazquez-Martin, Alejandro, et al.
Publicado: (2016)

Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo
por: Cufí, Sílvia, et al.
Publicado: (2013)

Mitochondrial fusion by pharmacological manipulation impedes somatic cell reprogramming to pluripotency: New insight into the role of mitophagy in cell stemness
por: Vazquez-Martin, Alejandro, et al.
Publicado: (2012)

Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: Utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment
por: Cufí, Sílvia, et al.
Publicado: (2012)

IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations
por: Vazquez-Martin, Alejandro, et al.
Publicado: (2013)

Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs
por: Corominas-Faja, Bruna, et al.
Publicado: (2012)

Oncobiguanides: Paracelsus' law and nonconventional routes for administering diabetobiguanides for cancer treatment
por: Menendez, Javier A., et al.
Publicado: (2014)

Metformin-induced preferential killing of breast cancer initiating CD44(+)CD24(−/low) cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
por: Cufí, Sílvia, et al.
Publicado: (2012)

The nutritional phenome of EMT-induced cancer stem-like cells
por: Cuyàs, Elisabet, et al.
Publicado: (2014)

Gerosuppressant Metformin: less is more
por: Menendez, Javier A., et al.
Publicado: (2011)

Metabostemness: Metaboloepigenetic reprogramming of cancer stem-cell functions
por: Menendez, Javier A., et al.
Publicado: (2014)

Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin
por: Cufí, Sílvia, et al.
Publicado: (2013)

Metformin and the ATM DNA damage response (DDR): Accelerating the onset of stress-induced senescence to boost protection against cancer
por: Menendez, Javier A., et al.
Publicado: (2011)

Oncoproteomic profiling with antibody microarrays
por: Alhamdani, Mohamed SS, et al.
Publicado: (2009)

Computer-aided discovery of biological activity spectra for anti-aging and anti-cancer olive oil oleuropeins
por: Corominas-Faja, Bruna, et al.
Publicado: (2014)

Contribution of oncoproteomics to cancer biomarker discovery
por: Cho, William CS
Publicado: (2007)

Metastasis-Associated Cell Surface Oncoproteomics
por: Karhemo, Piia-Riitta, et al.
Publicado: (2012)

Oncometabolic Nuclear Reprogramming of Cancer Stemness
por: Menendez, Javier A., et al.
Publicado: (2016)

Metformin: Multi-faceted protection against cancer
por: Del Barco, Sonia, et al.
Publicado: (2011)

Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype
por: Cuyàs, Elisabet, et al.
Publicado: (2015)

Anti-protozoal and anti-bacterial antibiotics that inhibit protein synthesis kill cancer subtypes enriched for stem cell-like properties
por: Cuyàs, Elisabet, et al.
Publicado: (2015)

Extra-virgin olive oil contains a metabolo-epigenetic inhibitor of cancer stem cells
por: Corominas-Faja, Bruna, et al.
Publicado: (2018)

Genomic and oncoproteomic advances in detection and treatment of colorectal cancer
por: McHugh, Seamus M, et al.
Publicado: (2009)

Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells
por: Corominas-Faja, Bruna, et al.
Publicado: (2014)

Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice
por: Punetha, Ankita, et al.
Publicado: (2023)

Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells
por: Oliveras-Ferraros, C, et al.
Publicado: (2012)

BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancer-initiating cells
por: Cuyàs, Elisabet, et al.
Publicado: (2017)

Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinib
por: Oliveras-Ferraros, Cristina, et al.
Publicado: (2011)

Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia
por: López Villar, Elena, et al.
Publicado: (2015)

Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas
por: Martin-Castillo, Begoña, et al.
Publicado: (2015)

Oncoproteomic Analysis Reveals Co-Upregulation of RELA and STAT5 in Carboplatin Resistant Ovarian Carcinoma
por: Jinawath, Natini, et al.
Publicado: (2010)

Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based “starvation” strategies in BRCA1 carriers
por: Cuyàs, Elisabet, et al.
Publicado: (2016)

Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Activation of the methylation cycle in cells reprogrammed into a stem cell-like state
por: Fernández-Arroyo, Salvador, et al.
Publicado: (2016)

Accelerated geroncogenesis in hereditary breast-ovarian cancer syndrome
por: Menendez, Javier A., et al.
Publicado: (2016)

Suppression of endogenous lipogenesis induces reversion of the malignant phenotype and normalized differentiation in breast cancer
por: Gonzalez-Guerrico, Anatilde M., et al.
Publicado: (2016)

Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer
por: Bosch-Barrera, Joaquim, et al.
Publicado: (2021)

Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity
por: Verdura, Sara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cbcuvkgn3fs1c58cefr7iphron